ARTICLE | Clinical News
Teriflunomide regulatory update
February 27, 2012 8:00 AM UTC
EMA accepted for review an MAA from Sanofi for teriflunomide to treat relapsing forms of multiple sclerosis (MS). The dihydroorotate dehydrogenase (DHODH) inhibitor is under review in the U.S., with ...